This inventor holds 3 USPTO granted patents. Top assignees: Assoicated Universties, Inc., Harvard College, Rijksuniversiteit Groningen. Active years: 1996-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 1996-2018
Title: Walter F. Mangel: Innovator in Molecular Technologies
Introduction
Walter F. Mangel is a notable inventor based in Shoreham, NY (US). He has made significant contributions to the field of molecular technologies, holding a total of 3 patents. His work focuses on innovative solutions that have the potential to impact various medical applications.
Latest Patents
Mangel's latest patents include groundbreaking inventions such as "Molecular sleds and uses thereof." This invention relates to compositions that may comprise a molecular sled linked to cargo, which can be utilized in methods for treating cancer, degenerative diseases, genetic diseases, and infectious diseases. Another significant patent is for "Activated recombinant adenovirus proteinases," which describes methods and constructs for producing activatable recombinant adenovirus proteinases. This patent also covers methods for purifying these proteinases and related immunospecific antibodies.
Career Highlights
Throughout his career, Walter F. Mangel has worked with esteemed organizations such as Associated Universities, Inc. and The Broad Institute, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Mangel has collaborated with notable colleagues, including Carl W. Anderson and Paul Blainey. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Walter F. Mangel's contributions to molecular technologies exemplify the spirit of innovation in the scientific field. His patents and collaborations highlight his commitment to advancing medical research and improving treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile